Frank Harder
Nessuna posizione attualmente
Storia della carriera di Frank Harder
Precedenti posizioni note di Frank Harder
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOPORTO A/S | Direttore Finanziario/CFO | 26/05/2010 | 01/01/2014 |
| Contatto Relazioni con gli Investitori | 01/01/2007 | 01/01/2014 | |
| Public Communications Contact | 01/01/2007 | 01/01/2014 | |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Direttore Finanziario/CFO | 01/01/2000 | - |
PhaseOneTrials A/S
 PhaseOneTrials A/S Miscellaneous Commercial ServicesCommercial Services PhaseOneTrials A/S is a Danish Contract Research Organization (CRO) that conducts clinical phase I trials and early phase II trials of new drug candidates. Phase I trials include studies in which a new drug is tested for the first time in healthy humans – also known as “First-in-Man” studies. Early phase II studies, or “Proof-of-Concept” studies, include testing a drug in small groups of patients to determine whether the drug has the desired effects on a given disease. | Direttore Finanziario/CFO | - | - |
Formazione di Frank Harder
| University of Copenhagen | Graduate Degree |
Statistiche
Distribuzione geografica
| Danimarca | 5 |
Posizioni
| Director of Finance/CFO | 3 |
| Graduate Degree | 1 |
| Investor Relations Contact | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOPORTO A/S | Health Technology |
| Aziende private | 2 |
|---|---|
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Health Technology |
PhaseOneTrials A/S
PhaseOneTrials A/S Miscellaneous Commercial ServicesCommercial Services PhaseOneTrials A/S is a Danish Contract Research Organization (CRO) that conducts clinical phase I trials and early phase II trials of new drug candidates. Phase I trials include studies in which a new drug is tested for the first time in healthy humans – also known as “First-in-Man” studies. Early phase II studies, or “Proof-of-Concept” studies, include testing a drug in small groups of patients to determine whether the drug has the desired effects on a given disease. | Commercial Services |
- Borsa valori
- Insiders
- Frank Harder
- Esperienza
